Large-scale linkage analyses suggest prenatal SARS‑CoV‑2 exposure is not associated with most neurodevelopmental or neurological diagnoses in early childhood. Restricting to pre–March 2022 births ...
Cox-adjusted analyses associated ≥1 year HRT use with reduced all-cause dementia (HR 0.90) and Alzheimer disease (HR 0.84), ...
Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what ...
There is something special about PAINWeek beyond the obvious Vegas setting and the usual conference buzz of caffeinated colleagues sprinting from session to session, having hallwa ...
FDA approved 40-mg and 50-mg BID leniolisib for APDS in children 4–11 years weighing ≥27 kg, representing the first ...
AD109 produced statistically significant AHI improvement versus placebo at 26 weeks (treatment difference –4.0 events/hour; ...
Jesse Goodman, MD, MPH, director of the Center on Medical Product Access, Safety and Stewardship (COMPASS) and attending ...
Johnson & Johnson now requires comprehensive pharmacy/medical claims elements to be submitted to its 340B ESP platform, with suspension of all 340B pricing within five business days after repeated ...
Nirmatrelvir-ritonavir (Paxlovid) provided no measurable benefit for patients with long COVID, according to results from RECOVER-VITAL ( NCT05595369 ), a phase 2 randomized, double-blind, ...
Aggregate OOP burden for generics exceeds brands due to utilization intensity, especially among Medicare beneficiaries with higher generic fill counts and near-parity annual OOP spending versus brands ...
National claims data (>104 million adults) showed higher unadjusted GLP-1 use in SMI, but adjustment for indications and ...
The law of rhythm states, simply, that everything moves in a predictable cycle. Day follows night and seasons follow one ...